<DOC>
	<DOCNO>NCT02869269</DOCNO>
	<brief_summary>Previous study show colorectal cancer patient ' prognosis overall survival relate immune cell expression patient ' tissue . However , circulate immune cell activity change patient ' blood study . The purpose study analyze variation circulate immune cell activity colorectal patient ' blood class clinical staging .</brief_summary>
	<brief_title>A Study Circulating Immune Cell Activity Changes Blood Colorectal Cancer Patients</brief_title>
	<detailed_description>The patient class clinical stag 1 . Early ( stage1+2 ) Late ( stage3+4 ) 2. regional lymph node metastasis 3 . Distant metastasis 4 . TNM stage</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>patient plan undergo colorectal cancer surgery . age &lt; 20 year old history hypersensitivity reaction propofol sevoflurane history previous cancer patient ongoing inflammation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>